4,771 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
People assigned to a diet, food or program and measured.
2020 / Randomized controlled trial (secondary analysis)
In a secondary analysis of a factorial randomized trial involving 3,365 adults followed for 22.3 years, smoking was associated with increased risk of gastric cancer incidence (OR, 1.72; 95% CI, 1.003-2.93) and mortality (HR, 2.01; 95% CI, 1.01-3.98). Garlic supplementation was associated with reduced gastric cancer mortality exclusively among individuals who never drank alcohol (HR, 0.33; 95% CI, 0.15-0.75; interaction P = .03). No significant interactions occurred between vitamin supplementation and lifestyle behaviors.
Guo Y, Li ZX, Zhang JY, et al. JAMA Netw Open, 2020. PMID 32589229
2019 / Randomized controlled trial
During 22 years of follow-up in 3,365 residents, garlic supplementation for 7.3 years significantly reduced gastric cancer mortality (hazard ratio 0.66, 95% CI 0.43 to 1.00), though it did not significantly reduce incidence (odds ratio 0.81, 95% CI 0.57 to 1.13). Vitamin supplementation significantly lowered both gastric cancer mortality (hazard ratio 0.48, 95% CI 0.31 to 0.75) and incidence (odds ratio 0.64, 95% CI 0.46 to 0.91).
Li WQ, Zhang JY, Ma JL, et al. BMJ, 2019. PMID 31511230
2018 / Bioavailability study
In 13 human participants, allicin bioavailability or bioequivalence was measured across 13 garlic supplements and 9 garlic preparations using breath allyl methyl sulfide after ingestion. Enteric tablets showed 36% to 104% bioavailability, which fell to 22% to 57% with high-protein meals. Non-enteric tablets achieved 80% to 111%, while cooked garlic foods lacking alliinase activity still yielded unexpected bioavailability ranging from 16% to 66%.
Lawson LD, Hunsaker SM Nutrients, 2018. PMID 29937536
2017 / Randomized controlled trial
Patients with coronary artery disease were randomized to receive garlic powder or dummy pills twice each day across a 3-month period. Ultrasound evaluation showed that flow-mediated dilation improved by 50.7% in the garlic group compared to the control group (p = 0.016). High-sensitivity C-reactive protein declined significantly with garlic but did not differ from control, and no alterations occurred in macrophage cholesterol efflux or mononuclear cell gene expression.
Mahdavi-Roshan M, Mirmiran P, Arjmand M, et al. Anatol J Cardiol, 2017. PMID 28554988
2016 / Randomized crossover trial
A randomized crossover pilot trial evaluated 26 adults with type 2 diabetes who consumed 1,200 mg of aged garlic extract or placebo daily for 4 weeks. Supplementation had no significant effect on insulin resistance or metabolic measures. In addition, aged garlic extract did not significantly alter markers of endothelial function, oxidative stress, or vascular inflammation in this high-risk population.
Atkin M, Laight D, Cummings MH J Diabetes Complications, 2016. PMID 26954484
2013 / Randomized controlled trial
In a trial of 56 patients with coronary artery disease, participants received garlic powder tablets or placebo twice daily for 3 months. Garlic resulted in minor intima-media thickness variation (-0.009 ± 0.007 mm), whereas placebo showed an increase (0.04 ± 0.01 mm), reflecting a significant between-group divergence (p < 0.001). Lipid and lipoprotein concentrations did not differ significantly between treatments.
Mahdavi-Roshan M, Zahedmehr A, Mohammad-Zadeh A, et al. Nutr Health, 2013. PMID 25573347
2012 / Randomized controlled trial
A randomized trial in 117 car battery industry workers evaluated garlic (1200 μg allicin three times daily) versus d-penicillamine (250 mg three times daily) for four weeks. Blood lead concentrations dropped significantly in both the garlic group (426.32 to 347.34 μg/L, p=0.002) and d-penicillamine group (417.47 to 315.76 μg/L, p=0.025), without differing significantly between groups. Garlic also improved symptoms such as headaches, irritability, deep tendon reflexes, and systolic blood pressure, while causing significantly fewer side effects than d-penicillamine (p=0.023).
Kianoush S, Balali-Mood M, Mousavi SR, et al. Basic Clin Pharmacol Toxicol, 2012. PMID 22151785
2012 / Masked factorial randomized placebo-controlled trial
Participants were tracked for 14.7 years following interventions in the Shandong Intervention Trial. Long-term supplementation with garlic or vitamins (C, E, and selenium) was linked to non-statistically significant decreases in gastric cancer incidence and mortality. However, vitamin supplementation significantly lowered combined deaths from gastric or esophageal cancer (hazard ratio = 0.51, 95% CI = 0.30 to 0.87; P = .014).
Ma JL, Zhang L, Brown LM, et al. J Natl Cancer Inst, 2012. PMID 22271764
2001 / Randomized controlled trial
In a 12-week trial, 146 volunteers took either an allicin-containing garlic pill or a placebo daily. Participants receiving garlic experienced significantly fewer colds than those on placebo (24 versus 65, P < .001). The garlic group also recorded fewer total days with viral illness (111 versus 366, P < .05) and shorter average symptom duration (1.52 versus 5.01 days, P < .001).
Josling P Adv Ther, 2001. PMID 11697022
1990 / Intervention trial with repeated testing on different days
Volunteers received intragastric infusions of ginger (2, 4, 6 g) and garlic (0.3, 0.75, 1.5, 3 g uncooked; 3 g cooked) on separate days to assess changes in gastric aspirate DNA content. Infusion of 2 g and 4 g ginger led to non-significant changes, while 6 g ginger significantly increased DNA-p/min by 3.23 +/- 1.02 (P < 0.05). Uncooked garlic at 0.3 g had no significant effect, but doses of 0.75, 1.5, and 3 g significantly increased DNA-p/min by 5.47 +/- 1.63 (P < 0.01), 10.42 +/- 3.46 (P < 0.01), and 29.26 +/- 4.55 (P < 0.001), respectively. Infusion of 3 g cooked garlic also significantly increased DNA-p/min by 21.43 +/- 4.62 (P < 0.001), with no significant difference between cooked and uncooked 3 g garlic.
Desai HG, Kalro RH, Choksi AP Indian J Med Res, 1990. PMID 2370094